Revenue Increased 40% Sequentially; Gross Margin Improved to 65.9%; Net Loss Narrowed 74% SequentiallyNet Cash Position of Approximately $14.9 Million, or Approximately $14.53 per Share - Approximately 12x Market CapitalizationRepurchased aggregate of 74,082 shares of Class B common stock at an average price of approximately $3.36 per share, for a total of approximately $249,194.
Completes SYMON-II clinical study enrollment and advances clinical validation activities.Achieves critical manufacturing milestone ahead of contractual deadline, strengthening supply chain and commercialization readiness.Targets FDA 510(k) submission in the first half of 2027.
Highlights for the quarter ended September 30, 2026:Management and advisory fees were $17.8 million for each of the three months ended September 30, 2026 and 2025. The quarter included a 26% increase in revenues from the Company's exchange-traded funds (ETFs). Management and advisory fees from separately managed accounts (SMAs) grew 2.0% for the quarter and 4.3% year-to-date.Operating income was $1.8 million (GAAP presentation) and $4.3 million advisor only presentation (Non-GAAP) for the quarter ended September 30, 2026 reflecting the Company's core asset management operations.Net income (loss) attributable to Horizon Kinetics Holding Corporation was a net loss of $18.4 million, or $0.98 per common share, and net income of $35.8 million, or $1.92 per share, for the three and nine months ended September 30, 2026, respectively. The net loss for the quarter was the result of unrealized declines in the fair value of certain key investment holdings, including those at consolidated investment products, while the year-to-date period continued to reflect unrealized gains at those same investment holdings.Assets under management (AUM) was $10.0 billion as of September 30, 2026, a decrease of 7.3% from June 30, 2026. AUM remains higher than the beginning of the year value of $9.6 billion, reflecting an increase of 3.9% from December 31, 2025.Board of Directors declared a $0.13 per share dividend.The Company's Board of Directors authorized a $25.0 million share repurchase program.
- Ensysce Biosciences Reports Third Quarter 2026 Financial Results and Business Highlights
- FGI Industries Announces Third Quarter 2026 Results
Boulevard
SEATTLE, WA / ACCESS Newswire / November 12, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today announced that the Company has entered into warrant inducement letter agreements with certain holders of its existing common warrants (the "Existing Warrants"), pursuant to which such holders have agreed to exercise in full for cash their Existing Warrants to purchase up to an aggregate of 2,777,778 shares of common stock of the Company ("common stock") at a reduced exercise price of $1.08 per share. In consideration for such cash exercises, the Company will issue new unregistered common stock purchase warrants (the "Inducement Warrants") to purchase up to an aggregate of 13,888,890 shares of common stock at an exercise price of $1.08 per share. The Inducement Warrants will be exercisable on or after the date on which the Company obtains the required stockholder approval and will expire five years after their initial exercise date. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to effective registration statements on Form S-1 (File No. 333-298483).
November 12, 2026
RECENT NEWS
Peraso Appoints Kevin Liu as Interim Chief Financial Officer
Technology
November 12, 2026
- IEH Corporation Filed Form 10-Q for Fiscal Quarter Ended September 30, 2026
- FRMO Corp. Announces Fiscal 2027 First Quarter Results and Conference Call
- Newsmax Announces Third Quarter 2026 Financial Results
- United States Antimony Corporation Reports Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results
Licensed, physician-led treatment center Beond will share de-identified ECG, adverse event and symptom data to help inform rigorous clinical trials of ibogaine
November 12, 2026
RECENT NEWS
PAYSON, UT / ACCESS Newswire / November 12, 2026 / WorkMax, a leading construction time tracking app and part of the Foundation Software product portfolio, has released a new resource describing how GPS time tracking works for construction crews and where it makes the biggest difference in labor management.
November 12, 2026
New scientific intelligence platform will combine technology, entrepreneurship and industrial expertise to advance material science and manufacturing.
November 12, 2026
Recognition highlights LaRoe's impact as a banking innovator, entrepreneur, and sustainability leader
November 12, 2026
Economy
ATHENS, GREECE / ACCESS Newswire / November 12, 2026 / Third Quarter / Nine-Month 2026 Results
November 12, 2026
RECENT NEWS
New planning resources connect HRM maturity assessments, program roadmaps and year-round security awareness campaigns to address risk across people and AI agents
A Vermont dairy farmer and cheesemaker who puts purpose ahead of profit brings that standard to FarmBot Tech's farming operations and satellite tools.Listen to Mateo Kehler talk with FarmBot Tech co-founder and CEO Detria Williamson:The84 Podcast - Episode 1 - In Conversation with Mateo Kehler
As VA centers host free screening events, advocates urge veterans with a history of military asbestos exposure to speak up about it
Analysis of federal records finds nearly 1 in 10 four- and five-star facilities have a serious red flag in their inspection history, and gives families a checklist for looking beyond the rating.
November 12, 2026
Economy
PHILADELPHIA, PA / ACCESS Newswire / November 12, 2026 / Grassi, a leading independent, employee-owned advisory, tax and accounting firm, announced the opening of a new office in the Greater Philadelphia region, further expanding the firm's presence in the Northeast and strengthening its ability to serve clients locally and nationally.
November 12, 2026
RECENT NEWS
Community health initiative highlights the connections between metabolic function, nutrition, hormonal balance, and sexual health in men.
Guide examines disputed lineage records and 190 historical flower tests reported under the Maui Wowie name
Company to Present and Host 1x1 Investor Meetings at the 18th Annual Southwest IDEAS Investor Conference on November 19th
A new research program introduces the AI Proximity Score, a 0 to 100 measure of how integrated AI has become in everyday life.
November 12, 2026
- PureCipher Announces Strategic Collaboration with SINTRONES to Advance Safe Physical AI
- CoreStack Launches TokenOps to Govern AI Alongside Cloud
- Who Is the Best Breast Augmentation Surgeon in Washington State?
- Trout CPA Appoints Matt Hartland Director of Business Valuation
- Space 11 Completes Private Placement at a Valuation of More Than $10.5 Billion
- Elektros To Meet with Highly Influential Individual Today to Explore Potential Acquisition of Multi-Port Ev Charging Patent
- Virtual Fashion Awards 2027 Returns to Miami in May, Opening Applications to Designers Worldwide, Including Asia-Pacific Region
- AI Search Engineers Explains How Moving Companies and Staffing Agencies Can Make Their Services Easier for AI Tools to Describe Accurately